[1]
2022. Treatment Patterns of Tocilizumab Utilization for Progressive Respiratory Distress during the COVID-19 Pandemic. International Journal of Statistics in Medical Research. 11, (Nov. 2022), 141–146. DOI:https://doi.org/10.6000/1929-6029.2022.11.18.